Spatially resolved transcriptomics provide a new method for cancer research

J Exp Clin Cancer Res. 2022 May 19;41(1):179. doi: 10.1186/s13046-022-02385-3.

Abstract

A major feature of cancer is the heterogeneity, both intratumoral and intertumoral. Traditional single-cell techniques have given us a comprehensive understanding of the biological characteristics of individual tumor cells, but the lack of spatial context of the transcriptome has limited the study of cell-to-cell interaction patterns and hindered further exploration of tumor heterogeneity. In recent years, the advent of spatially resolved transcriptomics (SRT) technology has made possible the multidimensional analysis of the tumor microenvironment in the context of intact tissues. Different SRT methods are applicable to different working ranges due to different working principles. In this paper, we review the advantages and disadvantages of various current SRT methods and the overall idea of applying these techniques to oncology studies, hoping to help researchers find breakthroughs. Finally, we discussed the future direction of SRT technology, and deeper investigation into the complex mechanisms of tumor development from different perspectives through multi-omics fusion, paving the way for precisely targeted tumor therapy.

Keywords: Cancer; Research Progress; Spatially resolved transcriptomics.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasms* / genetics
  • Transcriptome*
  • Tumor Microenvironment / genetics